Konjenital nötropeni: İki vaka sunumu
Öz
Anahtar Kelimeler
Kaynakça
- 1. Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: Diagnosis, molecular bases and patient management. Orphanet J Rare Dis 2011;6:26.
- 2. Hauck F, Klein C. Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr Opin Allergy Clin Immunol 2013; 13: 596-606.
- 3. Özbek N. Konjenital nötropenilere genetik bakış. TJH 2009; 26: 1-8.
- 4. Zeidler C, Germeshausen M, Klein C, Welte K. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol 2009;144:459-67.
- 5. Kostmann R. İnfantile genetic agranulocytosis. Acta Pediatr Scand 1956; 45:1-78.
- 6. Germeshausen M, Grudzien M, Zeidler C, Abdollahpour H, Yetgin S, Rezaei N, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotypephenotype associations. Blood 2008; 111:4954–7.
- 7. Karaca NE, Aksu G, Gülez N, Azarsız E, Kavaklı K, Klein C, et al. Clinical, Laboratory and Molecular Approach to Ten Children with Congenital Neutropenia. J Pediat Res 2016;3:7-12.
- 8. Carlsson G, van’t Hooft I, Melin M, Entesarian M, Laurencikas E, Nennesmo I, et al. Central nervous system involvement in severe congenital neutropenia: Neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med 2008; 264:388–400.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Diğer
Yazarlar
Banu İnce Durhan
*
Bu kişi benim
Türkiye
Yayımlanma Tarihi
30 Haziran 2022
Gönderilme Tarihi
25 Mart 2022
Kabul Tarihi
25 Mart 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 15 Sayı: (Özel Sayı-1) 21. Mersin Pediatri Günleri Bildiri Kitabı